5-hydroxytryptamine receptor 7 activity modulators and their method of use Grant US-11897870-B2 United States of America 13 Feb 2024
Crystal forms and production methods thereof Grant US-11767293-B2 United States of America 26 Sep 2023
Modified release formulations and uses thereof Grant US-11654113-B2 United States of America 23 May 2023
Crystal forms and production methods thereof Grant US-11370753-B2 United States of America 28 Jun 2022
5-hydroxytryptamine receptor 7 activity modulators and their method of use Grant US-11192871-B2 United States of America 07 Dec 2021
Modified release formulations and uses thereof Grant US-11160758-B2 United States of America 02 Nov 2021
MODIFIED RELEASE FORMULATIONS AND USES THEREOF Application WO-2020247627-A1 World Intellectual Property Organisation (WIPO) 10 Dec 2020
Crystal forms and production methods thereof Grant US-10800738-B2 United States of America 13 Oct 2020
Crystal forms and production methods thereof Grant US-10577317-B2 United States of America 03 Mar 2020
5-hydroxytryptamine receptor 7 activity modulators and their method of use Grant US-10544117-B2 United States of America 28 Jan 2020
Crystal forms and production methods thereof Grant US-10377708-B2 United States of America 13 Aug 2019
NONRACEMIC MIXTURES AND USES THEREOF Application WO-2019113079-A1 World Intellectual Property Organisation (WIPO) 13 Jun 2019
PSYCHOTROPIC AGENTS AND USES THEREOF Application WO-2018098497-A1 World Intellectual Property Organisation (WIPO) 31 May 2018
METHOD FOR TREATING SCHIZOPHRENIA AND RELATED DISEASES WITH A COMBINATION THERAPY Application WO-2012002583-A1 World Intellectual Property Organisation (WIPO) 05 Jan 2012